MaxWell Biosystems at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

MaxWell Biosystems brings 2 presentations to SfN 2026 in Washington, and exhibits at Booth 636. Its presentations centre on high-density microelectrode array profiling of human organoids and cell models of neurodegeneration. One thread examines early hyperexcitability and axonal dysfunction in a human iPSC-derived model of GRN-FTD.

OrganizationSfN 2026 Attendance
MaxWell Biosystems
Zurich, Switzerland
Electrophysiology and neurotechnology companies
Swiss maker of high-resolution microelectrode array systems for neural cultures, organoids and drug discovery.
Booth
Exhibiting at Booth 636
Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from MaxWell Biosystems

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction